Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M M, van Noesel"'
Autor:
L. S. Hiemcke-Jiwa, M. T. Meister, E. Martin, M. P. Dierselhuis, L. M. Haveman, R. W. J. Meijers, B. B. J. Tops, P. Wesseling, P. J. van Diest, J. M. van Gorp, J. Y. Hehir-Kwa, I. A. E. M. van Belzen, J. J. Bonenkamp, M. M. van Noesel, U. Flucke, L. A. Kester
Publikováno v:
Acta Neuropathologica, 145, 149-152
Hiemcke-Jiwa, L S, Meister, M T, Martin, E, Dierselhuis, M P, Haveman, L M, Meijers, R W J, Tops, B B J, Wesseling, P, van Diest, P J, van Gorp, J M, Hehir-Kwa, J Y, van Belzen, I A E M, Bonenkamp, J J, van Noesel, M M, Flucke, U & Kester, L A 2023, ' NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target ', Acta Neuropathologica, vol. 145, no. 1, pp. 149-152 . https://doi.org/10.1007/s00401-022-02515-3
Acta Neuropathologica, 145, 1, pp. 149-152
Hiemcke-Jiwa, L S, Meister, M T, Martin, E, Dierselhuis, M P, Haveman, L M, Meijers, R W J, Tops, B B J, Wesseling, P, van Diest, P J, van Gorp, J M, Hehir-Kwa, J Y, van Belzen, I A E M, Bonenkamp, J J, van Noesel, M M, Flucke, U & Kester, L A 2023, ' NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target ', Acta Neuropathologica, vol. 145, no. 1, pp. 149-152 . https://doi.org/10.1007/s00401-022-02515-3
Acta Neuropathologica, 145, 1, pp. 149-152
Contains fulltext : 291288.pdf (Publisher’s version ) (Open Access) 01 januari 2023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a6916dfd0b7010ebda572ae702352a
http://hdl.handle.net/2066/291288
http://hdl.handle.net/2066/291288
Autor:
L S, Hiemcke-Jiwa, S, van Belle, A, Eijkelenboom, J H M, Merks, M M, van Noesel, S E J, Kaal, J M A, Pijnenborg, J, Bulten, B B J, Tops, C P, van de Ven, J M, van Gorp, R R, de Krijger, E, Cheesman, A M, Kelsey, L A, Kester, U, Flucke
Publikováno v:
Annals of Diagnostic Pathology, 60
DICER1-related tumors occur hereditary or sporadically, with high-grade malignancies sharing clinicopathological and (epi)genetic features. We compared 4 pleuropulmonary blastomas (PPBs) and 6 sarcomas by mutation analysis, whole transcriptome sequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::166ab62f37a95ec4d7fcca4920f5b5dd
https://doi.org/10.1016/j.anndiagpath.2022.152002
https://doi.org/10.1016/j.anndiagpath.2022.152002
Autor:
A.W. Langerak, M. van Grotel, E.M.M. (Esther) van Lieshout, Rob Pieters, M. Passier, M. M. van Noesel, Jessica G.C.A.M. Buijs-Gladdines, Jules P.P. Meijerink, E. R. Van Wering, N. B. Burger, Willem Kamps, H B Beverloo, Anjo J.P. Veerman
Publikováno v:
Leukemia, 22(1), 124-131. Nature Publishing Group
Leukemia, 22(1), 124-31. Nature Publishing Group
van Grotel, M, Meijerink, J P, van Wering, E R, Langerak, A W, Beverloo, HB, Buijs-Gladdines, J G, Burger, N B, Passier, M, van Lieshout, E M, Kamps, W A, Veerman, A J P, van Noesel, M M & Pieters, R 2008, ' Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences ', Leukemia, vol. 22, no. 1, pp. 124-131 . https://doi.org/10.1038/sj.leu.2404957
Leukemia, 22, 124-131. Nature Publishing Group
Leukemia, 22(1), 124-31. Nature Publishing Group
van Grotel, M, Meijerink, J P, van Wering, E R, Langerak, A W, Beverloo, HB, Buijs-Gladdines, J G, Burger, N B, Passier, M, van Lieshout, E M, Kamps, W A, Veerman, A J P, van Noesel, M M & Pieters, R 2008, ' Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences ', Leukemia, vol. 22, no. 1, pp. 124-131 . https://doi.org/10.1038/sj.leu.2404957
Leukemia, 22, 124-131. Nature Publishing Group
Pediatric T-cell acute lymphoblastic leukemia (T-ALL) is characterized by chromosomal rearrangements possibly enforcing arrest at specific development stages. We studied the relationship between molecular- cytogenetic abnormalities and T-cell develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf7c3d7d583d3e32649d57e5ac7b7637
https://doi.org/10.1038/sj.leu.2404957
https://doi.org/10.1038/sj.leu.2404957
Publikováno v:
Cancer. 80(5)
Despite the excellent prognosis for neuroblastoma 4S (NBL 4S; with S indicating "special"), 10-25% of these patients nevertheless do not survive. Since the first description of this subgroup of disseminated neuroblastoma with a favorable natural outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24fe96fd4ab09297bb5296ec05bc85e3
https://pubmed.ncbi.nlm.nih.gov/9307181
https://pubmed.ncbi.nlm.nih.gov/9307181
Autor:
Orbach D; Department of Paediatric Oncology, Institut Curie, Paris, France., Brennan B, Casanova M, Bergeron C, Mosseri V, Francotte N, Van Noesel M, Rey A, Bisogno G, Pierron G, Ferrari A
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2013 Nov; Vol. 60 (11), pp. 1826-32. Date of Electronic Publication: 2013 Jul 16.